Adeno-associated virus (AAV) and the other parvoviruses have long been known to inhibit proliferation of nonpermissive cells. The mechanism of this inhibition is not thoroughly understood. To learn how AAV interacts with host cells, we have begun an investigation into AAV's relationship with adenovirus (Ad), AAV's most efficient helper virus. AAV, but not UV-inactivated AAV, delayed Ad-induced cytotoxicity and inhibited Ad E2a gene expression. AAV, but not UV-inactivated AAV or a recombinant AAV vector, inhibited Ad DNA replication. To determine whether AAV or its replication (Rep) proteins alter Ad early gene expression, we measured steady state E2a mRNA levels in AAV and Ad coinfected cultures and in a cell line (Neo6) that inducibly expresses the Rep proteins. AAV, but not UV-AAV, and Rep expression resulted in diminution of E2a protein and mRNA levels. To determine whether the AAV Rep proteins directly affect the individual Ad early promoters, we constructed luciferase reporter plasmids containing each of the five early promoters. Cotransfection of Ad-luciferase and an AAV rep gene-expressing plasmid in HeLa cells demonstrated that Rep78 repressed the E1a, E2a, and E4 promoters but trans-activated the E1b and E3 promoters. In the presence of a cotransfected E1a-expressing plasmid, Rep78 repressed expression from all five promoters. These results indicate that Rep may have different effects on the Ad early promoters dependent upon the presence of the E1a trans-activating protein.
INTRODUCTION

Adeno-associated virus (AAV) is classified in the
Dependovirus genus of the family Parvoviridae because it normally depends on the assistance of a helper virus to efficiently complete its replication cycle (reviewed in Berns and Giraud, 1996) . Adenovirus (Ad) is the most efficient helper for AAV, although human papillomavirus (HPV) (Ogston et al., 2000; Walz et al., 1997) , cytomegalovirus, vaccinia virus, Epstein-Barr virus, and herpes virus will also support variable levels of AAV replication (Atchison, 1970; Dolin and Rabson, 1973; Buller et al., 1981; McPherson et al., 1985) . AAV replicates in the absence of helper virus infection when cultured cells have been synchronized or challenged with DNA-damaging agents (Yakobson et al., 1987 (Yakobson et al., , 1989 . Recently it has been suggested that AAV replicates autonomously in differentiating keratinocytes (Meyers et al., 2000) . In the absence of a helper virus coinfection, AAV integrates into the long arm of chromosome 19 (reviewed in Chiorini et al., 1996) . The provirus remains at this locus until the host cell is infected with a helper virus and subsequently "rescues" the provirus, thus initiating the replication cycle.
Although AAV has never been conclusively linked to any disease or pathogenic condition, the virus exerts profound effects on the replication of its helper virus and the infected cell. In a helper virus free environment, AAV infection of cells alters the expression of several cell cycle regulated genes (Hermanns et al., 1997) , promotes differentiation-like effects (Klein-Bauerschmitt et al., 1992; Winocour et al., 1992) , and induces a late S-phase and/or G2-phase cell cycle block (Winocour et al., 1988) . AAV infection of primary human cells induces a cell cycle block that is correlated with a decrease in retinoblastoma (Rb) protein phosphorylation and an increase in p21 Cip gene expression (Hermanns et al., 1997) . Retrovirus vectors expressing AAV replication proteins induced G 1 and G 2 cell cycle arrest (Saudan et al., 2000) .
AAV also exerts inhibitory effects on the Ad helper virus in coinfected cells. AAV, but not defective interfering (DI) particles, blocks Ad DNA replication Casto et al., 1967a,b; Laughlin et al., 1979) . These results suggest that AAV gene expression or amplification of the AAV genome may be essential for Ad inhibition. AAV also inhibits Ad-induced transformation (reviewed in Carter, 1990) . Inhibition of Ad-induced tumorigenicity and cellular transformation has been attributed to the AAV terminal repeat sequences and AAV genes (de la Maza and Carter, 1981; Khleif et al., 1991) , whereas the effects on Ad replication have been attributed to expression of the AAV replication (rep) gene (Weitzman et al., 1996) .
The AAV rep gene encodes four replication proteins: Rep78, Rep68, Rep52, and Rep40. Rep78 and Rep68 are pleiotropic modulators of the AAV replication cycle regulating viral gene expression, DNA replication, site-specific integration into the chromosome 19 locus, and cellular gene expression. In viral DNA replication they bind to a 16-bp Rep binding site (RBS) found in the A-stem of the covalently closed end of the AAV origin of replication. Upon binding, either of the larger Rep proteins will make a site-specific strand-specific cut at a terminal resolution site (trs) 17 nucleotides from the RBS Snyder et al., 1990) . This cleavage results in covalent attachment of the Rep protein to the 5Ј end of the viral DNA (Snyder et al., 1990; Prasad and Trempe, 1995; Prasad et al., 1997) . In the absence of helper virus, Rep78 or Rep68 will bind and cleave the cellular RBS found in the chromosome 19 integration site to mediate viral DNA integration (Urcelay et al., 1995) . In addition to DNA replication and integration, the Rep proteins regulate viral gene expression. Rep78 and Rep68 repress transcription from the p5 promoter in the presence and absence of Ad coinfections (Beaton et al., 1989; Kyostio et al., 1995; . In the presence of Ad coinfection, Rep78 and Rep68 activate transcription of the p19 and p40 promoters (McCarty et al., 1991; . Rep78 or Rep68 have also been reported to block translation of cap gene mRNA (Trempe and Carter, 1988) .
Transient expression of the rep gene prevents cellular DNA replication, which may be caused by inhibition of cell cycle progression or a direct effect on DNA synthesis (Yang et al., 1994 (Yang et al., , 1995 Saudan et al., 2000) . Two different cell lines have been established that express the rep gene under the control of inducible transcription promoters (Yang et al., 1994; Holscher et al., 1994) . Both cell lines express Rep proteins that retain wild-type functions. However one of the cell lines arrests in S-phase upon induction of Rep expression (Yang et al., 1994) . The rep gene has also been shown to inhibit human herpesvirus , HIV (Antoni et al., 1991; Ritter et al., 1992) , SV40 (Bantel-Schaal and ZurHausen, 1988; Yang et al., 1995) , and bovine papillomavirus replication (Hermonat, 1992) . In a variety of plasmid cotransfection studies, rep gene expression inhibits gene expression from some heterologous promoters (Antoni et al., 1991; Horer et al., 1995; Khleif et al., 1991; Labow et al., 1987) and increases expression from the c-sis gene promoter (Wonderling and Owens, 1996) and the CMV early promoter (Wonderling et al., 1997) .
We have begun a study of the relationship between AAV and Ad as a model system for understanding AAV and host-cell interactions. We present evidence that AAV and its encoded Rep proteins inhibit Ad replication and that these inhibitions are due, in part, to inhibition of E2a gene expression. The Rep protein-mediated alterations on Ad gene expression are due to effects on Ad early gene promoters as well as on E1a-mediated trans-activation of early gene expression.
RESULTS
AAV inhibits Ad-induced cytotoxicity
Ad-infected cells develop cytopathic effects (CPE) characterized by progressive deterioration of cell viability and eventual cell death. To determine whether AAV coinfection affects Ad-mediated CPE, HeLa cells were coinfected with Ad (multiplicity of infection (m.o.i.) ϭ 5) and either AAV or UV-inactivated AAV (m.o.i. ϭ 400). Twentyfour hours after infection and at every 24 h thereafter, viability assays were performed. Trypan blue counting of the percentage of viable cells showed that a decrease in viability for the Ad-infected cultures is first noticeable after the 72-h time point (Fig. 1A) . By 96 h, the Ad-infected or the Ad-and UV-AAV-coinfected cultures were approximately 50% viable. In contrast, the 50% viability level for the AAV-and Ad-coinfected cultures was not reached until approximately 132 h after infection.
The AAV-mediated delay of Ad cytotoxicity was verified in a similar assay in which viability was measured with an MTT assay. A decrease in cell viability was observed after the 72-h time point for both the Ad and the Ad plus UV-AAV coinfected cultures (Fig. 1B) . However the Ad and AAV coinfected cultures continued to grow until the 96-h time point after which the cells began to die. These results support the conclusion that AAV, but not UVinactivated AAV, delayed Ad-mediated cytotoxicity.
UV-AAV competes with normal AAV for virus receptor binding
Cellular AAV uptake has been proposed to occur via virus binding to a receptor composed of a heparin sulfate proteoglycan (Summerford and Samulski, 1998) and possibly the fibroblast growth factor receptor (Qing et al., 1999) . Integrin ␣ V ␤ 5 is also involved in virus internalization (Summerford et al., 1999) . One possible explanation for the different effects of AAV and UV-AAV in the toxicity assays is that UV irradiation damaged the virion, preventing it from binding to its receptor. To determine whether UV-AAV competes with normal particles for receptor binding, Ad-infected HeLa cells were transduced with an AAV-␤gal vector at an m.o.i. of 1, and two different amounts of an AAV-gfp (gfp, green fluorescent protein) vector that was either UV-inactivated or left untreated. Figure 2 shows that in the presence of either the AAV-gfp or the UV-inactivated AAV-gfp vector, there was approximately a 2.5-fold decrease in AAV-␤gal transduction. Both the untreated and the UV-irradiated AAV-gfp vector inhibited transduction at similar levels. The level of competition for the AAV receptor was comparable to that observed in the presence of 1 mM heparin, which effectively prevents AAV binding (Summerford and Samulski, 1998) . This indirect evidence suggests that UV treatment does not affect virus binding to its receptor.
AAV-mediated inhibition of Ad DNA replication AAV-mediated inhibition of Ad infection is both time and dose dependent Casto et al., 1967a,b) . If Ad infection precedes AAV infection by more than 4 h, AAV does not block Ad replication. Alternatively, if AAV infection accompanies or precedes Ad infection, then Ad replication is blocked in an AAV dose-dependent manner. To verify that Ad replication is inhibited during the course of an AAV coinfection, human KB cells were infected with AAV, or UV-inactivated AAV, 5 h prior to Ad infection. Twenty-four hours after Ad infection the cultures were harvested and viral DNA isolated. The Ad DNA was digested with EcoRI, separated by agarose gel electrophoresis, and probed with radioactively labeled Ad DNA. Ad replication in the presence of two different concentrations of AAV was substantially inhibited (compare lane 1 to lanes 3 and 4, Fig. 3 ). However UVinactivated AAV was unable to block Ad replication (compare lane 1 to lanes 5 and 6, Fig. 3) .
Similar experiments were performed using a recombinant AAV vector (AAV-␤gal) that lacks rep and cap genes ( Table 1 ). HeLa cells were coinfected with Ad5 (m.o.i. ϭ 1) and different amounts of AAV, UV-AAV, or AAV-␤gal. Ad DNA replication was analyzed by Southern hybridization as described above and the results were measured by densitometer analysis. In Table 1 we see that AAV, but not UV-AAV or AAV-␤gal, inhibited Ad DNA replication in HeLa cells (expts 1 and 2). It is interesting to note also that Ad replication in the presence of UV-AAV or AAV␤gal is apparently more abundant than in the absence of any AAV. The results shown in Fig. 3 and Table 1 suggest that amplification of AAV or expression of the AAV genome is required for inhibition of Ad replication. These results also indicate that the virion is not sufficient for inhibition of Ad replication. The inoculum was removed, replaced with fresh serum-containing medium, and incubated at 37°C for the duration of the experiment. Twenty-four hours after infection and every 24 h thereafter, the cultures were harvested and counted as described in the text. (B) HeLa cells in phenol red-free MEM were plated in 24-well dishes in triplicate. The cultures were infected with Ad5 and AAV or UV-inactivated AAV. Twenty-four hours after infection and every 24 h thereafter, MTT viability assays were performed as described in the text. OD 595 refers to the amount of absorbance at 595 nm.
AAV and Rep protein expression inhibit Ad E1A and E2A protein expression AAV-mediated inhibition of Ad DNA replication may be due to several possible mechanisms. AAV or its gene products may directly inhibit Ad DNA replication by competing with the Ad genome for limited replication factors. Alternatively, Ad early gene expression may be inhibited such that viral DNA replication is prevented. Immunoblot analyses were performed to determine whether Ad early gene expression is affected by AAV infection. HeLa cells were infected with two different m.o.i. of AAV and Ad. Forty-eight hours later the cultures were harvested and analyzed by SDS-PAGE and immunoblotting. In Fig. 4A it is apparent that AAV has a dose-dependent effect on expression of the Ad E2a and E1a gene products. When a similar experiment was performed using normal and UV-AAV, comparable results were obtained (Fig. 4B ). AAV Rep protein expression was observed in the AAV-infected cultures (Fig. 4B ). As seen in Fig. 4 , the AAVmediated inhibition of E2a expression is variable and dose dependent. Comparison of E2a expression from four independent infections revealed that at an AAV m.o.i. of Ն100, the E2a level in an AAV coinfection was 33% of the level of E2a expression in UV-AAV coinfections. When the AAV m.o.i. was decreased to Ն10, the E2a expression level in AAV coinfection was 49% of the level observed in UV-AAV coinfection (data not shown). These results indicate that AAV coinfection results in inhibition of Ad early gene expression and that this inhibition is correlated with AAV Rep protein expression.
To determine whether Rep protein expression alone is sufficient for inhibition of Ad early gene expression, similar experiments were performed in a cell line (Neo6) that inducibly expresses Rep proteins. Neo6 cells were derived from Ad E1a-and E1b-transformed 293 cells (Yang et al., 1994) . These cells express a fully functional AAV rep gene under the control of a mouse metallothionein transcription promoter but lack all other viral elements. Rep protein expression is inducible in these cells by the addition of heavy metal salts to the culture medium. Neo5 cells, which do not express Rep proteins, were used as a control in these experiments. Rep expression was induced 7-10 h before Ad infection and the cultures were harvested 48 h after virus adsorption. Immunoblot analyses of infected Neo5 and Neo6 cells were then used to detect E1a and E2a protein expression. In Fig. 5A we see that induction of Rep in Neo6 cells results in inhibition of E2a expression. This inhibition is not observed in the control Neo5 cells. Unlike the results shown in Fig. 4 , E1a levels are not affected by heavy metal induction in this experiment. The 293 cell-derived Neo5 and Neo6 cells carry an endogenous copy of 11% of the left end of the Ad5 genome (Graham et al., 1977) . Presumably, the E1a proteins detected in Fig. 5A emanate from the infecting viral genome as well as from the endogenous copy of the E1a gene. To determine whether the induced Rep protein in Neo6 cells affects the expression of the endogenous E1a gene, Neo5 and Neo 6 cells were induced for 40 h and then analyzed by immunoblots. Figure 5B shows that neither the heavy metal salts nor Rep expression alters E1a expression in Neo5 or Neo6 cells. These results, combined with those shown in Fig. 4 , suggest that AAV or Rep expression is able to suppress E1a expression from within the context of the Ad chromosome but not from the context of the cellular chromosome.
AAV and Rep expression inhibit Ad E2a mRNA accumulation
The AAV Rep proteins have been reported to have effects on mRNA accumulation from several viral and cellular genes. AAV rep gene expression has also been reported to affect protein translation (Trempe and Carter, 1988; Takeuchi et al., 2000) . To determine whether the AAV and Rep effects on Ad E2a gene expression result from transcriptional or posttranscriptional events, we analyzed the steady state levels of E2a mRNA in HeLa cells coinfected with Ad and AAV, and in Neo5/6 cells infected with Ad. In the experiments shown in Figs. 4 and 5, Ad E2a expression was analyzed by immunoblot analyses up to 48 h after infection. Therefore it was not possible to determine whether the lower levels of E2A proteins resulted from AAV-and Rep-mediated inhibition of gene expression or prevention of Ad genome replication. Amplification of the Ad genome would result in fewer transcription templates and lower protein levels. To determine whether AAV and Rep expression had direct effects on early gene expression, we artificially prolonged the early phase of Ad infection. DNA synthesis inhibitors have been used to prolong the early phase of Ad infection and prevent the early-to-late transition in the Ad replication cycle (Wilson et al., 1979; reviewed in Horwitz, 1990) . This allows for accumulation of early gene mRNAs that are then more easily detected by Northern analyses. HeLa cells were coinfected with Ad and AAV or UV-AAV, in the presence and absence of 10 mM hydroxyurea (HU). Forty-eight hours later the cultures were harvested and total RNA isolated. The RNA was separated by agarose electrophoresis and analyzed by Northern hybridizations using radioactively labeled E2a or actin gene probes. In the presence of normal AAV there was a twoto threefold decrease in the level of E2a mRNA levels compared to UV-AAV treated or untreated Ad-infected HeLa cells (Fig. 6A) . In a parallel set of cultures, HU was added to the culture medium 5 h after Ad adsorption. As occurred in the absence of HU, E2a mRNA was diminished two-to threefold in the presence of normal AAV compared to UV-AAV. Equal loading of RNA was verified by comparable levels of actin mRNA. Similar analyses of E2a mRNA levels were performed on Ad-infected Neo5/6 cells (Fig. 6B) . It was evident that Rep expression prevented E2a mRNA accumulation when Ad replication was blocked by HU or in the absence of the drug. These results suggest that in the absence of AAV and Ad amplification, AAV infection and Rep expression inhibits E2a gene expression. That the Rep protein from AAV is capable of blocking Ad early gene expression in HU- 
AAV Rep78 protein alters gene expression from Ad early transcription promoters
The E1a gene is the first viral gene to be expressed in an Ad infection. The products of the E1a gene have wide-ranging effects on cellular and Ad gene expression (reviewed in Flint and Shenk, 1997) . The 13S mRNAencoded, 289 amino acid (a.a.) E1a protein stimulates Ad gene expression by trans-activating the Ad transcription promoters. These trans-activating effects are mediated primarily by conserved region 3 (CR3), which is found only in the 289 a.a. protein. From our virus infection experiments it is clear that AAV and the Rep proteins inhibit Ad early gene expression. Rep protein effects may be due to direct action on the Ad promoters or to an inhibition of E1a's ability to trans-activate the Ad promoters. To determine which of these possibilities occurs, we amplified the transcription promoters of the five Ad early genes using PCR and linked them to a luciferase reporter gene. Each of the Ad/luc plasmids was then transfected into HeLa cells along with a Rep78-expressing plasmid (pCDMRep78) or control plasmid (pCDM8). Reporter gene expression from the E1a, E2a, and E4 promoters was suppressed in the presence of the wild-type form of the rep gene (Fig. 7A) . The effects on the E2a promoter were the most variable of the three suppressed promoters in that Rep-mediated suppression ranged from almost no suppression to slightly over twofold as shown here. For the E1b and E3 promoters we consistently observed Rep-mediated trans-activation.
To determine whether Rep affected the E1a protein's ability to trans-activate the Ad early promoters, a similar series of luciferase assays were performed using a plasmid that expresses the 289 a.a. E1a protein (White et al., 1991) . To ensure that there were equivalent amounts of E1a protein expressed in cotransfections with pCDM8 and pCDMRep78, preliminary transfections and immunoblot analyses were performed. These experiments showed that when the E1a-expressing plasmid was transfected in a 2:1 ratio over the Rep plasmids, there was no difference between the two cotransfections in the level of expressed E1a protein (results not shown). Therefore the E1a, Rep, and Ad/luc plasmids were transfected onto HeLa cells in a 2:1:0.5 g ratio, respectively. Forty-eight hours later luciferase assays were performed. As expected, the presence of the 289 a.a. E1a protein resulted in substantially more luciferase activity. However, Rep78 was found to inhibit expression from all five Ad promoters (Fig. 7B) . The greatest suppression was observed for the E4 and E2 promoters. Rep78 apparently responds to E1a in different ways depending on the Ad transcription promoter in question. For the E1b and E3 promoters, there is less luciferase activity in the presence of Rep78 when E1a is also present, suggesting that E1a causes Rep78 to become a suppressor, whereas Rep78 prevents E1a-mediated trans-activation of the E1a, E2, and E4 promoters.
DISCUSSION
In this study we report on an analysis of AAV interactions with adenovirus. In the coinfected cell, AAV utilizes Ad proteins and RNA to efficiently express its genome and replicate itself. However this Ad benevolence comes at a price for the helper in terms of limited Ad replication. Here we report that the Ad infectious cycle is delayed in the presence of an AAV coinfection. The delay is manifest in a prolonged survival of the host cell. The delay is not realized with UV-inactivated AAV, suggesting that it is not the virion that causes the delay even though UV-AAV binds to the virus receptor. Expression of the Ad E3 death protein is required for the efficient lysis of Ad-infected cells and mediates the release of Ad from cells after the infectious cycle is complete (Tollefson et al., 1996a,b) . Rep78-mediated suppression of E1a-mediated transactivation of the E3 promoter (Fig. 7) is a possible explanation for how AAV delays Ad-mediated cell killing.
Early analyses of AAV and Ad interactions revealed that Ad production was limited by up to 100-fold and Ad DNA replication was limited by up to 10-fold Casto et al., 1976a,b) . AAV defective interfering particles did not display similar levels of Ad inhibition. The mechanism of this inhibition has never been thoroughly studied. Our results shown here, and those from the earlier studies, strongly suggest that expression of AAV genes is required for inhibition of Ad DNA replication. The AAV rep gene has been shown to block viral and cellular DNA replication in a variety of plasmid transfection studies (Antoni et al., 1991; Hermonat, 1992; Kleinschmidt et al., 1995; Yang et al., 1995; Weitzman et al., 1996) . Weitzman et al. (1996) were the first to demonstrate that a plasmid-transfected rep gene could inhibit Ad DNA amplification using in situ hybridizations. The rep gene's suppression of viral and cellular DNA replication is in contrast to results obtained when AAV infects primary cultures or some cell lines (Klein-Bauerschmitt et al., 1992; Winocour et al., 1992) . In these assays, an inactivated AAV particle was capable of inducing a G 2 /M phase block. Thus AAV's inhibitory effects on the helper virus and the host cell are due to multiple viral elements.
AAV gene products may prevent Ad replication directly by binding to Ad DNA or sequestering essential cellular or viral replication factors. Alternatively, AAV may inhibit Ad replication indirectly by blocking the expression of replication-essential Ad early genes. One published report indicated that transfection of a Rep-expressing plasmid had no apparent effect on E2a protein expression as measured in immunofluorescent assays (Weitzman et al., 1996) . Another report indicated that AAV infection inhibited E1b 55-kDa expression in an Ad-transformed hamster cell line (Ostrove et al., 1981) . Our results showing suppression of E1a and E2a gene expression in AAV and Ad-coinfected cells and suppression of E2a expression in Ad-infected Neo6 cells are consistent with the hypothesis that AAV inhibits Ad replication by inhibiting early gene expression.
The Rep proteins suppress translation of mRNAs from the AAV p40, cap gene, transcription promoter (Trempe and Carter, 1988) . Recently, similar effects on translation have been obtained in in vitro assays (Takeuchi et al., 2000) . Our results in AAV and Ad-coinfected HeLa cells and Ad-infected Neo6 cells suggest that AAV and Repmediated inhibition of E2a mRNA accumulation is responsible for the diminution of E2a protein levels. Other work from our laboratory shows that neither Rep78 nor Rep52 affect E2a mRNA stability, suggesting that the affect on mRNA is due to changes in transcription (S. Nada, X.-J. Jing, and J. P. Trempe, unpublished observation). That work also demonstrates that the Rep proteins exert posttranscriptional effects on E2a gene expression. Although Rep proteins may also have direct effects on Ad DNA replication, it is possible that the effects on E2a gene expression may be sufficient for blocking Ad replication.
Each of the Ad early transcription promoters was isolated and cloned into luciferase gene reporter plasmids to determine how they are affected by a cotransfected rep gene plasmid. Interestingly, in the absence of a cotransfected E1a gene, Rep caused an inhibition of expression from the E1a, E2a, and E4 plasmids but trans-activated the E3 and E1b promoters. However in the presence of E1a 289 a.a. protein expression, the Rep proteins caused a decrease in expression from all five early promoters. Thus in the presence of the E1a protein the Rep protein becomes a promiscuous repressor of the Ad early transcription promoters. These analyses were limited to luciferase enzyme assays and they were not accompanied by luc mRNA measurements. Therefore we cannot differentiate between transcriptional and posttranscriptional effects.
Examination of the Ad early promoters suggests possible transcription factors that may be targeted by the Rep proteins. With the exception of E1b, all of the early promoters contain one or more ATF/CREB binding sites (Flint and Shenk, 1997) . ATF/CREB elements are bound by the cAMP response element binding protein that in turn is activated by phosphorylation mediated by protein kinase A (PKA). The AAV Rep78 and Rep52 proteins have been shown to interact with protein kinase X (PKX), a member of the PKA family (Chiorini et al., 1998; DiPasquale and Stacey, 1998) . Rep association with PKA results in inhibition of its ability to phosphorylate CREB, which in turn prevents activation of ATF/CREB-containing promoters. The pCDMRep78 plasmid used in our transient luc transfection assays expresses predominantly the Rep78 protein. Therefore CREB inactivation may explain some of our results. However the E3 promoter, which also has an ATF/CREB site, is activated by Rep78 in the absence of E1a. Thus Rep inhibitory effects are more complicated than simple sequestration of protein kinases that modify ATF/CREB. All of the Ad early promoters also contain TATA, or noncanonical TATA boxes. The CR3 domain of the E1a 289 a.a. trans-activates these TATA elements. One group has shown that the Rep protein associates with the TATA box-binding protein, TBP (Hermonat et al., 1998) . Another group has shown that the Rep protein disrupts TBP binding to the TATA element (Su et al., 2000) . However both E1b and E3 promoters have TATA elements but are activated by Rep in the absence of E1a. These data, and our evidence that Rep is a promiscuous suppressor in the presence of the E1a 289 a.a. protein, suggest that Rep-specific interactions may prevent E1a activation of TBP function. One possible explanation of Rep effects in the presence of E1a is that coexpression of these proteins is toxic to the cell (Saudan et al., 2000) . Mouse NIH3T3 cells begin to die within 60-72 h after they were cotransduced with retroviruses expressing the Ad E1a gene and the AAV Rep78 protein (Saudan et al., 2000) . This report may explain our previous results in which we observed that Rep protein expression prevented E1a/ras-mediated transformation of NIH3T3 cells (Khleif et al., 1991) . Conversely, induction of Rep expression in 293-derived Neo6 cells resulted in cytostasis rather than cytotoxicity after 2 weeks in culture (Yang et al., 1994) . The luciferase assays shown in Fig. 7 were performed 48 h after transfection and there were no obvious cytotoxic effects observed at this time point. The cell killing observed in the NIH 3T3 cells was not measured until at least 60 h after retrovirus transduction; therefore, it is difficult to compare the data in Fig. 7 with the Saudan et al. (2000) report.
The studies presented here have demonstrated that AAV and Rep protein-mediated inhibition of Ad gene expression plays an important role in blocking Ad replication. Given published reports of AAV virion effects on host cells and Rep effects on mRNA translation, suppression of transcription is not the only means by which this virus interacts with its helper viruses and host cells. The biological significance of these inhibitory effects may be to allow AAV to effectively compete with Ad to insure its survival in the coinfected cell. As the biochemical mechanisms of Rep protein functions are unraveled, a better understanding of this unique virus will be attained.
MATERIALS AND METHODS
Cells and viruses
Ad type 2 and Ad type 5 (Ad2 and Ad5) were originally obtained from the American Type Cell Culture (ATCC). Neo6 and Neo5 cells were produced by stable introduction of the AAV rep gene under the control of the mouse metallothionein transcription promoter into human 293 cells (Yang et al., 1994) . Neo6 cells express Rep protein when induced with heavy metal salts, while Neo5 cells do not express Rep. HeLa, KB, and 293 cells were grown in Eagle's minimum medium (MEM) supplemented with glutamine, penicillin (50 mg/ml), streptomycin (50 mg/ml), and 10% fetal bovine serum. Neo6 and Neo5 cells were grown in the same supplemented MEM, except containing 10% dialyzed fetal bovine serum and geneticin at 0.5 mg/ml. All cells were maintained as monolayer cultures at 37°C in a 5% CO 2 atmosphere.
AAV was prepared by calcium phosphate DNA transfection (Ausubel et al., 1987) of the pAV2 plasmid (Laughlin et al., 1983) on to 20 ϫ 15-cm plates of 293 cells (each containing 1-1.4 ϫ 10 7 cells) that were infected with Ad5 at an m.o.i. of 5 in serum-free medium at 37°C for 1-1.5 h. Serum was added to a final concentration of 10% and the cultures incubated at 37°C. The cultures were harvested 48-72 h postinfection (p.i.) and AAV was purified by CsCl equilibrium centrifugation and titered by indirect immunofluorescence as described .
Recombinant AAV expressing the Escherichia coli ␤-galactosidase gene under the control of the CMV early promoter (AAV-␤gal) was prepared by calcium phosphate plasmid cotransfection of Ad-infected 293 cells. pAAV/Ad (20 g) (Samulski et al., 1989) and 5 g pAV␤gal were cotransfected onto each of 10-and 15-cm dishes of 293 cells that were infected with Ad5 at 5 m.o.i. Seventy-two hours later the cells were harvested by scraping and vector was purified using CsCl density gradient centrifugation as described above. AAV-␤gal was titered by transduction of Ad-infected HeLa cells followed by staining with X-gal. Recombinant AAV expressing the green fluorescent protein gene under the control of the CMV early promoter was prepared in similar packaging assays using the pTRUF-5 vector plasmid (kindly provided by Dr. N. Muzyczka).
UV inactivation of AAV and recombinant AAV was performed by diluting virus in serum-free medium in six-well culture dishes. The virus was then irradiated in a UV Stratalinker (Stratagene Model 1800) at an energy level of 2.4 ϫ 10 5 J/cm 2 . Complete inactivation of AAV was verified by coinfection of HeLa cells with Ad and the inactivated virus. Forty-eight hours after infection the cultures were harvested and examined for replicative form AAV by Southern hybridization analyses.
Adenovirus was obtained by infection of 293 cells at an m.o.i. of 5. The cultures were harvested 48-72 h later and virus was purified and titered as described (Winters and Russell, 1971) .
Plasmids used in this study
Plasmid pAV2 containing the entire AAV genome sequence cloned in pBR322 (Laughlin et al., 1983) was used in generating wild-type AAV virus. Plasmid pCDMRep78 contains the wild-type Rep gene cloned in pCDM8 (Invitrogen Inc.) under the control of CMV early promoter (Yang and Trempe, 1993) . Plasmid pCMVE1a13S expresses the 289 a.a. E1a protein (White et al., 1991) . The pAAV/Ad, pAV␤gal, and pTRUF-5 plasmids are described above.
Vent DNA polymerase (New England Bio-Lab) was used in polymerase chain reactions (PCR) to amplify DNA fragments containing the Ad2 early transcription promoter elements. The primer sets were created with flanking HindIII and XhoI sites for cloning purposes. The sizes, location in the Ad2 genome, and primers used for each of the promoters are as follows: E1a, 532 bp, nucleotides 1-532, CTCGAGCATCATCATAAT-ATACCTTA and AAGCTTGGAGGAGAAAACTCTACTCG; E1b, 261 bp, nucleotides 1438-1699, CTCGAG-TCTGGGCAACCTTGGA, and AAGCTTGAGGTCAGATG-TAACCAAGAT; E2a, 286 bp, nucleotides 27,052-27,338, AAGCTTAGATCAGCTTCGGCGCAC and CTCGAGATA-TCATGTGGGGTCC; E3, 311 bp, nucleotides 27,328-27,639, CTCGAGTCAACGGAATCCGCGCC and AAGCT-TGGAGCTCACCGACTCGTC; E4, 360 bp, nucleotides 35,577-35,937, CTCGAGCATCATCATAATATACCTTA and AAGCTTTCGACACGGCACCAGCTCA. Each amplified product was inserted into the pGL3-Basic luc reporter vector (Promega Inc.) and verified by manual DNA sequencing (Sequenase 2.0 DNA sequencing system, U.S. Biochemicals).
Antibodies
Antibody against Ad 72-kDa DNA binding protein, a mouse monoclonal IgG (MAb 37-3), was kindly provided by Dr. I. Kovesdi of GenVec Inc. AAV Rep protein-specific polyclonal antibodies were obtained from rabbits immunized with a recombinant Rep protein expressed from E. coli (Trempe et al., 1987) . Antibody against Ad E1a protein, a polyclonal rabbit IgG (13S-5), was obtained from Santa Cruz Biotechnology Inc. . Alkaline phosphatase-conjugated anti-rabbit IgG (Cat. No. 31340) was obtained from Pierce Co.
Virus infection and induction of Neo5/6 cells
Virus infections were carried out in serum-free MEM medium and adsorption was for 1-2 h at 37°C. The medium was then either replaced with regular serumcontaining medium or was supplemented with serum to a final concentration of 10%. For heavy metal ion (HM) induction to express Rep protein in Neo5/6 cells, CdSO 4
and ZnCl 2 were included in the culture medium at final concentrations of 2 and 100 M, respectively, 7-10 h before Ad infection, and left in the medium until harvest.
Indirect AAV receptor binding assay
HeLa cells (1 ϫ 10 5 ) were plated in 24-well dishes. The cultures were transduced with 1 m.o.i. of AAV-␤gal alone, or along with 2 or 25 m.o.i. of AAV-gfp or UV-inactivated AAV-gfp. One hour after adding the vector, the medium was removed and the cell monolayer washed with phosphate buffered saline. Normal medium containing Ad5 at an m.o.i. of 5 was placed on the cultures for 48 h. Alternatively 1 mM heparin was used in place of the AAV-gfp vector to block AAV binding to its receptor. After 48 h the cultures were harvested by scraping, lysed, and ␤-galactosidase assays were performed using the Galactostar kit (Tropix).
Cytotoxicity assays
HeLa cells (1.5 ϫ 10 4 per well, approximately 10% confluent) were plated in 24-well dishes in triplicate. The cultures were infected with Ad5 (m.o.i. ϭ 5) alone or together with AAV or UV-inactivated AAV (m.o.i. ϭ 400) in 200 l of serum-free medium at 37°C for 90 min. The inoculum was removed, replaced with fresh serum-containing medium, and incubated at 37°C for the duration of the experiment. Twenty-four hours after infection and every 24 h thereafter, for 144 h, cells were harvested by trypsinization to obtain single-cell suspensions and collected by low-speed centrifugation. Cell pellets were resuspended in 50-100 l of culture medium and stained with 0.025% trypan blue. Fifteen microliters of each cell suspension was microscopically examined and the percentage of viable cells was determined.
HeLa cells (1.5 ϫ 10 4 per well, approximately 10% confluent) in phenol red-free MEM were plated in 24-well dishes in triplicate. The cultures were infected with Ad5 and AAV or UV-inactivated AAV as described in the cytotoxicity section above. Twenty-four hours after infection and every 24 h thereafter, for 144 h, MTT viability assays were performed as described (Mossman, 1983) .
Ad DNA replication assay
An amount of 1 ϫ 10 6 KB or HeLa cells in 35 mm dishes was infected with variable amounts of AAV, UV-AAV, or recombinant AAV␤gal. Five hours later the cultures were infected with Ad2 at an m.o.i. of 5 or Ad5 at an m.o.i. of 1. Forty-eight hours after Ad infection the cultures were harvested and low molecular weight DNA isolated by the method of Hirt (1967) . The DNA was digested with restriction endonuclease EcoRI and separated by agarose gel electrophoresis. Southern transfer and hybridization with a 32 P-labeled genomic Ad probe were used to reveal the multiple bands of the Ad genome EcoRI fragments. Probe preparation was performed us-ing a random primer, radioactive labeling kit (Boehringer Mannheim). The blot was then exposed to X-ray film.
Densitometer analyses were performed on the X-ray film using a Kodak Image Station 440CF and Kodak Digital Science 1D image analysis software.
Protein extraction and immunoblot analysis
Isolation of nuclear extracts, SDS-PAGE, and immunoblot analysis of viral proteins were performed as described previously (Yang et al., 1994) .
Northern analysis of Ad early gene expression
Total RNA was isolated from infected cells using TRIZOL reagent (BRL Life Technologies) according to the manufacturer's instructions. Total RNA (30 g) was separated by formaldehyde agarose gel electrophoresis. RNA was transferred to Nytran membrane (Schleicher & Schuell) as described (Ausubel et al., 1987) . RNA was immobilized by UV cross-linking using a Stratalinker. A RiboProbe in vitro Transcription System (Promega) was used with cloned and linearized Ad E2a or cellular ␤-actin gene fragments to generate 32 P-labeled ribonucleic acid probes. The Northern blots were prehybridized, hybridized, washed, and exposed to X-ray film as described (Ausubel et al., 1987) .
Plasmid transfections and luciferase reporter assays
Calcium phosphate-DNA transfection mixes were prepared as described (Ausubel et al., 1987) in a 200-l volume containing 1 g of promoter plasmid (pE2aluc, pE1aluc, pE1bluc, pE4luc, and pE3luc) plus 2 g pCDMRep78 or pCDM8. Fifty microliters of the mixture was then added to 6 ϫ 10 4 HeLa cells in 24-well plates. For E1a plasmid transfections, 200 l calcium phosphate-DNA transfection mixes were prepared containing 0.5 g of the Ad/luc plasmids, 1 g of the Rep plasmids, and 2 g of the pCMVE1a13S plasmids. (The E1a plasmids were kindly provided by Dr. Eileen White.)
Forty-eight hours after transfection cell lysates were prepared and luciferase assays performed using the Luciferase Assay System (Promega) as described by the manufacturer. Enzyme activity was reported after standardization of the amount of protein in the extracts.
